Top 5 Net Payout Yield Stocks To Watch For 2014

Twitter Inc.�� decision to list on the New York Stock Exchange is a victory for the Big Board that opens the door for more Internet listings.

Twitter, which announced the decision in a regulatory filing yesterday, joins Pandora Media Inc., LinkedIn Corp. and Yelp Inc. as Internet companies that chose the NYSE since 2011. While Nasdaq OMX Group Inc. scored a coup by landing the Facebook Inc. (FB) initial public offering in 2012, its reputation was tarnished by a software malfunction that delayed trading for the social network. Competition for IPOs is critical for both exchanges, which get about a fifth of revenue from listing fees.

��ompanies like to list where other, similar companies are listed,��Richard Kline, a Menlo Park, California-based partner at the Goodwin Procter law firm who focuses on technology company funding, said in a phone interview. ��nybody associated with the offering will get an uplift from it, and next time they meet with a company�� board they can say ��e won Twitter.���

5 Best Integrated Utility Stocks To Invest In Right Now: Nike Inc.(NKE)

NIKE, Inc., together with its subsidiaries, engages in the design, development, marketing, and sale of footwear, apparel, equipment, and accessory products for men, women, and children worldwide. The company offers products in the categories of running, training, basketball, soccer, sport-inspired casual shoes, and kids? shoes. It also markets footwear designed for baseball, cheerleading, football, golf, lacrosse, outdoor activities, skateboarding, tennis, volleyball, walking, wrestling, and other athletic and recreational uses. In addition, Nike sells sports apparel and accessories, sports-inspired lifestyle apparel, athletic bags, and accessory items; and markets apparel with licensed college, professional team, and league logos. Further, the company sells performance equipment, including bags, socks, sport balls, eyewear, timepieces, electronic devices, bats, gloves, protective equipment, golf clubs, and other equipment designed for sports activities under the brand na me of NIKE; and various plastic products to other manufacturers. It offers products under the trademarks of Cole Haan, Converse, Chuck Taylor, All Star, One Star, Star Chevron, Jack Purcell, Hurley, and Umbro. The company sells its products through retail accounts, its own retail stores and Internet sales, independent distributors, and licensees. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

Advisors' Opinion:

• [By Ben Levisohn]

  But regardless of the merits, Alcoa (AA), Hewlett-Packard (HPQ) and Bank of America (BAC) are being booted from the index and replaced with Visa (V), Goldman Sachs (GS) and Nike (NKE).

• [By WALLSTCHEATSHEET]

  Nike offers athletic and fitness related apparel and footwear products to user base that is showing impressive signs of growth. The stock has been on a bullish move higher that has taken it to all-time highs, however, it has now pulled back a bit so may need time before making its next move. Over the last four quarters, investors in the company have generally been pleased as earnings have improved and revenue figures have been on the rise. Relative to its peers and sector, Nike has been an average performer. Look for Nike to OUTPERFORM.

• [By Ben Levisohn]

  Shares of Lululemon have gained 0.8% to $51.47 at 3:31 p.m., while the Gap is little changed at $42.33. Nike (NKE) has risen 0.3% to $75.32, while Under Armour (UA) has jumped 1.4% to $107.51. Maybe it wasn’t the uniforms after all.

• [By Rich Duprey]

  Be a good sport
  There's a difference between the controversy wracking Reebok now and that, say, of Nike (NYSE: NKE  ) , which has gone out of its way to manufacture controversy at times, standing by Tiger Woods during his personal divorce problems.�Sports figures tend to have a more wholesome image, which is why they're among the biggest endorsers of products, but they, too, become embroiled in situations that leave the companies that sign their paychecks running for the exits.

Top 5 Net Payout Yield Stocks To Watch For 2014: Wind Works Power Corp (WWPW)

Wind Works Power Corp. (Wind Works), incorporated on November 20, 2002, the Company intends to develop wind parks. The Company will assemble land packages, secure requisite environmental permitting, provide wind testing by erecting towers to measure wind speed. The Company operates 4.6 megawatts in Germany, in which it has a 49% ownership stake.

The Company�� projects include Ganaraska Wind Park, Settlers Landing, Skyway 126, Ganaraska and Thunder Spirit. The Company focuses to develop 77 megawatts of near-term permitted projects in Germany; 50 megawatts of FIT contracted projects in Ontario; and 320 megawatts of projects in the United States.

Advisors' Opinion:

• [By Peter Graham]

  Small cap green stocks Geo Finance Corporation (OTCMKTS: GEFI), Dragon Polymers Inc (OTCMKTS: DRAG) and Wind Works Power Corp (OTCMKTS: WWPW) have been getting some extra attention lately from various investment newsletters or investor alerts. However, two of these small cap green stocks have also been the subject of paid promotions or investor relations types of activities. So will these green small cap stocks produce some greenbacks for investors and traders alike? Here is a closer look and a reality check:

Top 5 Net Payout Yield Stocks To Watch For 2014: Durata Therapeutics Inc (DRTX)

Durata Therapeutics, Inc., incorporated on November 4, 2009, is a pharmaceutical company focused on the development and commercialization of therapeutics for patients with infectious diseases and acute illnesses. The Company enroll and dose patients in two global Phase III clinical trials with its product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections (abSSSI). Dalbavancin is an intravenous antibiotic product candidate designed for once-weekly dosing. In addition to abSSSI, the Company focuses on the development of dalbavancin for additional indications, including osteomyelitis, diabetic foot infection and pneumonia.

As of December 31, 2011, Dalbavancin had already completed three Phase III clinical trials, in which more than 1,000 patients in total received dalbavancin. Dalbavancin achieved its primary efficacy endpoint of non-inferiority in each of these three completed Phase III clinical trials when compared to linezolid, cefazolin or vancomycin, three of the standard-of-care agents for uncomplicated skin and skin structure infections (uSSSI), and complicated skin and skin structure infections (cSSSI). Its two ongoing Phase III clinical trials are designed to compare dalbavancin to vancomycin, with an option to switch to oral linezolid, under the new FDA draft guidance.

The Company competes with Pfizer, Cubist Pharmaceuticals, Inc., Theravance, Inc., Forest Laboratories, Inc., Sanofi-Aventis Ltd., The Medicines Company, Trius Therapeutics, Inc., Cempra, Inc., Rib-X Pharmaceuticals, Inc., Paratek Pharmaceuticals, Inc., Nabriva Therapeutics AG, Tetraphase Pharmaceuticals, Inc. and Furiex Pharmaceuticals, Inc.

Advisors' Opinion:

• [By Lisa Levin]

  Durata Therapeutics (NASDAQ: DRTX) shares climbed 5.30% to $14.18. The volume of Durata Therapeutics shares traded was 861% higher than normal. The FDA Advisory Committee unanimously recommended the approval of Durata's Dalvance.

• [By Bob's Stocks]

  Durata Therapeutics (DRTX) is developing Dalbavancin, a once a week, intravenous antibiotic product candidate, for the treatment of patients with acute bacterial skin and skin structure infections, or ABSSSI. The company is expected to file a NDA (New Drug Application) at any moment and MAA (Marketing Authorization Application) at the end of 2013.

Top 5 Net Payout Yield Stocks To Watch For 2014: Mitsubishi Motors Corp (MMTOF)

MITSUBISHI MOTORS CORPORATION is engaged in the development, production and sale of general and small-sized passenger vehicles, mini-vehicles, sport utility vehicles (SUVs), trucks and automobile parts, as well as the inspection and maintenance of new vehicles. In addition, the Company is also engaged in the financing business including automobile leasing and sales finance. Advisors' Opinion:

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Japanese stocks rose Wednesday after a lower open, managing solid gains with most other Asian markets were closed for the Christmas holiday. The Nikkei Stock Average (JP:NIK) climbed 0.8% to 16,009.99, its first close above the 16,000 level since late 2007. The broader Topix ended with a more modest 0.1% rise. Seven & I Holdings Co. (JP:3382) (SVNDF) , operators of the 7-Eleven convenience-store chain, rose 1.5% as a Nikkei Asian Review report said it planned to pay about 楼5 billion yen to purchase nearly half of Bals, which runs home-and-kitchen-furnishings retailer Francfranc. Chip maker Renesas Electronics Corp. (JP:6723) (RNECY) was a strong performer, rallying 6.5% after suffering a sizeable drop in the previous session. On the downside, shares of Softbank Corp. (JP:9984) (SFTBF) fell 0.5%, after a separate article in the Nikkei saying that previously reported plans by the firm to buy T-Mobile US Inc. (TMUS) through its newly acquired Sprint (S) unit would value the transaction at more than 2 trillion yen ($19 billion) and would take place as early as next spring. Auto-maker stocks were mostly higher after trading mixed following the release of Japanese car-sales data for November. Toyota Motor Corp. (JP:7203) (TM) added 0.2%, Honda Motor Co. (JP:7267)